The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo

Journal of Clinical Investigation

Volumn 118, Issue 11, 2008, Pages 3639-3650

  Vukmanovic Stejic, Milica ^a   Agius, Elaine ^a,b   Booth, Nicola ^a   Dunne, Padraic J ^c   Lacy, Katie E ^a,b   Reed, John R ^a,b   Sobande, Toni O ^a   Kissane, Steven ^d   Salmon, Mike ^d   Rustin, Malcolm H ^b   Akbar, Arne N ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD39 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TUBERCULIN;

ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD4+FOXP3+ T CELL; CELL KINETICS; CELL PROLIFERATION; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INFLAMMATION; MEMORY T LYMPHOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN;

ANTIGENS; ANTIGENS, CD4; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOLOGIC MEMORY; KINETICS; SKIN; T-LYMPHOCYTES, REGULATORY;

EID: 55849107041     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI35834     Document Type: Article

References (65)

1. Shevach, E.M. 2002. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389-400.
2. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531-562.
3. Coombes, J.L., Robinson, N.J., Maloy, K.J., Uhlig, H.H., and Powrie, F. 2005. Regulatory T cells and intestinal homeostasis. Immunol.Rev. 204:184-194.
4. Belkaid, Y. 2007. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7:875-888.
5. Apostolou, I., and von Boehmer, H. 2004. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199:1401- 1408.
6. Cobbold, S.P., et al. 2004. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J. Immunol. 172:6003-6010.
7. Walker, L.S., Chodos, A., Eggena, M., Dooms, H., and Abbas, A.K. 2003. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med. 198:249-258.
8. Vukmanovic-Stejic, M., et al. 2006. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 116:2423-2433.
9. Farzaneh, L., Kasahara, N., and Farzaneh, F. 2007. The strange case of TGN1412. Cancer Immunol. Immunother. 56:129-134.
10. Tarbell, K.V., et al. 2007. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204:191-201.
11. Chatenoud, L., and Bluestone, J.A. 2007. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat. Rev. Immunol. 7:622-632.
12. Mottet, C., Uhlig, H.H., and Powrie, F. 2003. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol. 170:3939- 3943.
13. Joffre, O., et al. 2008. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat. Med. 14:88-92.
14. Gregori, S., et al. 2001. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167:1945-1953.
15. Dannull, J., et al. 2005. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J. Clin. Invest. 115:3623-3633.
16. Roncarolo, M.G., and Battaglia, M. 2007. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 7:585-598.
17. Akbar, A.N., Vukmanovic-Stejic, M., Taams, L.S., and Macallan, D.C. 2007. The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat. Rev. Immunol. 7:231-237.
18. van Amelsfort, J.M., Jacobs, K.M., Bijlsma, J.W., Lafeber, F.P., and Taams, L.S. 2004. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 50:2775-2785.
19. Ruprecht, C.R., et al. 2005. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J. Exp. Med. 201:1793-1803.
20. Uhlig, H.H., et al. 2006. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J. Immunol. 177:5852-5860.
21. Reed, J.R., et al. 2004. Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J. Exp. Med. 199:1433-1443.
22. Orteu, C.H., et al. 1998. The role of apoptosis in the resolution of T cell-mediated cutaneous inflammation. J. Immunol. 161:1619-1629.
23. Gerdes, J., et al. 1984. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133:1710-1715.
24. Kalish, R.S., and Johnson, K.L. 1990. Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol. J. Immunol. 145:3706-3713.
25. Clark, R.A., and Kupper, T.S. 2007. IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood. 109:194-202.
26. Allan, S.E., et al. 2005. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J. Clin. Invest. 115:3276-3284.
27. Gavin, M.A., et al. 2006. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. U. S. A. 103:6659-6664.
28. Walker, M.R., Carson, B.D., Nepom, G.T., Ziegler, S.F., and Buckner, J.H. 2005. De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. Proc. Natl. Acad. Sci. U. S. A. 102:4103-4108.
29. Pandiyan, P., Zheng, L., Ishihara, S., Reed, J., and Lenardo, M.J. 2007. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8:1353-1362.
30. Tiemessen, M.M., et al. 2007. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. U. S. A. 104:19446-19451.
31. Scott-Browne, J.P., et al. 2007. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 204:2159-2169.
32. Levings, M.K., Sangregorio, R., and Roncarolo, M.G. 2001. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:1295-1302.
33. Allan, S.E., et al. 2007. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19:345-354.
34. Tran, D.Q., Ramsey, H., and Shevach, E.M. 2007. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood. 110:2983-2990.
35. Liu, W., et al. 2006. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203:1701-1711.
36. Seddiki, N., et al. 2006. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203:1693-1700.
37. Borsellino, G., et al. 2007. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 110:1225-1232.
38. Deaglio, S., et al. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204:1257-1265.
39. Hirahara, K., et al. 2006. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J. Immunol. 177:4488-4494.
40. Schaerli, P., et al. 2004. A skin-selective homing mechanism for human immune surveillance T cells. J. Exp. Med. 199:1265-1275.
41. Lombardi, G., Sidhu, S., Batchelor, R., and Lechler, R. 1994. Anergic T cells as suppressor cells in vitro. Science. 264:1587-1589.
42. Taams, L.S., et al. 2001. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31:1122-1131.
43. Hoffmann, P., et al. 2006. Isolation of CD4+CD25+ regulatory T cells for clinical trials. Biol. Blood Marrow Transplant. 12:267-274.
44. Chong, B.F., Murphy, J.E., Kupper, T.S., and Fuhlbrigge, R.C. 2004. E-selectin, thymus- and activation-regulated chemokine/CCL17, and intercellular adhesion molecule-1 are constitutively coexpressed in dermal microvessels: a foundation for a cutaneous immunosurveillance system. J. Immunol. 172:1575-1581.
45. Baecher-Allan, C., and Hafler, D.A. 2006. Human regulatory T cells and their role in autoimmune disease. Immunol. Rev. 212:203-216.
46. Korn, T., et al. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13:423-431.
47. Suffia, I.J., Reckling, S.K., Piccirillo, C.A., Goldszmid, R.S., and Belkaid, Y. 2006. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J. Exp. Med. 203:777-788.
48. Kasow, K.A., et al. 2004. Human CD4+CD25+ regulatory T cells share equally complex and comparable repertoires with CD4+. J. Immunol. 172:6123-6128.
49. Scheinberg, P., et al. 2007. The clonal composition of human CD4+CD25+Foxp3+ cells determined by a comprehensive DNA-based multiplex PCR for TCRB gene rearrangements. J. Immunol. Methods. 321:107-120.
50. Fantini, M.C., et al. 2004. Cutting edge: TGF-{beta} induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172:5149-5153.
51. Coombes, J.L., et al. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204:1757-1764.
52. Sun, C.M., et al. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204:1775-1785.
53. Chatenoud, L., Thervet, E., Primo, J., and Bach, J.F. 1994. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 91:123-127.
54. Smith, J.A., Tso, J.Y., Clark, M.R., Cole, M.S., and Bluestone, J.A. 1997. Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy. J. Exp. Med. 185:1413-1422.
55. Taams, L.S., et al. 2002. Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur. J. Immunol. 32:1621-1630.
56. Lombardi, G., et al. 2000. Type 1 IFN maintains the survival of anergic CD4+ T cells. J. Immunol. 165:3782-3789.
57. LaSalle, J.M., Tolentino, P.J., Freeman, G.J., Nadler, L.M., and Hafler, D.A. 1992. Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J. Exp. Med. 176:177-186.
58. Patel, D.M., et al. 1999. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. J. Immunol. 163:5201-5210.
59. Barnaba, V., Watts, C., de Boer, M., Lane, P., and Lanzavecchia, A. 1994. Professional presentation of antigen by activated human T cells. Eur. J. Immunol. 24:71-75.
60. Migita, K., and Ochi, A. 1993. The fate of anergic T cells in vivo. J. Immunol. 150:763-770.
61. Taams, L.S., et al. 1998. Anergic T cells actively suppress T cell responses via the antigen-presenting cell. Eur. J. Immunol. 28:2902-2912.
62. Chai, J.G., et al. 1999. Anergic T cells act as suppressor cells in vitro and in vivo. Eur. J. Immunol. 29:686-692.
63. Leen, A.M., et al. 2006. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat. Med. 12:1160-1166.
64. June, C.H., and Blazar, B.R. 2006. Clinical application of expanded CD4+25+ cells. Semin. Immunol. 18:78-88.
65. Roncador, G., et al. 2005. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur. J. Immunol. 35:1681-1691.